Header Logo

Connection

MICHAEL VOLK to Risk Factors

Back to Details
This is a "connection" page, showing publications MICHAEL VOLK has written about Risk Factors.
MICHAEL VOLK
Connection Strength
0.796
Risk Factors
  1. Preventing Readmissions of Hepatic Encephalopathy: Strategies in the Acute Inpatient, Immediate Postdischarge, and Longitudinal Outpatient Setting. Clin Liver Dis. 2024 05; 28(2):359-367.
    View in: PubMed
    Score: 0.077
  2. Discussion: Hospital readmissions in cirrhosis and the importance of treating alcohol use disorder. Dig Liver Dis. 2020 07; 52(7):788-789.
    View in: PubMed
    Score: 0.059
  3. Cardiovascular Complications After Liver Transplant: A Shifting Clinical Presentation. Liver Transpl. 2018 10; 24(10):1331-1332.
    View in: PubMed
    Score: 0.053
  4. The "PHS Increased Risk" Label Is Associated With Nonutilization of Hundreds of Organs per Year. Transplantation. 2017 07; 101(7):1666-1669.
    View in: PubMed
    Score: 0.048
  5. Strategies to Reduce 30-Day Readmissions in Patients with Cirrhosis. Curr Gastroenterol Rep. 2017 Jan; 19(1):1.
    View in: PubMed
    Score: 0.047
  6. The Epidemiology of Cirrhosis in the United States: A Population-based Study. J Clin Gastroenterol. 2015 Sep; 49(8):690-6.
    View in: PubMed
    Score: 0.043
  7. Analytic morphomics identifies predictors of new-onset diabetes after liver transplantation. Clin Transplant. 2015 May; 29(5):458-64.
    View in: PubMed
    Score: 0.042
  8. Variation among United States hospitals in inpatient mortality for cirrhosis. Clin Gastroenterol Hepatol. 2015 Mar; 13(3):577-84; quiz e30.
    View in: PubMed
    Score: 0.040
  9. Organ quality and quality of life after liver transplantation. Liver Transpl. 2011 Dec; 17(12):1443-7.
    View in: PubMed
    Score: 0.033
  10. Patient decision making about organ quality in liver transplantation. Liver Transpl. 2011 Dec; 17(12):1387-93.
    View in: PubMed
    Score: 0.033
  11. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol. 2012 Feb; 107(2):247-52.
    View in: PubMed
    Score: 0.032
  12. Centers for Disease Control 'high-risk' donors and kidney utilization. Am J Transplant. 2010 Feb; 10(2):416-20.
    View in: PubMed
    Score: 0.029
  13. Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. Gastroenterology. 2008 Nov; 135(5):1568-74.
    View in: PubMed
    Score: 0.027
  14. Liver transplantation for hepatocellular carcinoma: who benefits and who is harmed? Gastroenterology. 2008 May; 134(5):1612-4.
    View in: PubMed
    Score: 0.026
  15. Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3. Cancer Biomark. 2007; 3(2):79-87.
    View in: PubMed
    Score: 0.023
  16. The Liver Transplant Comorbidity Index (LTCI): A composite index of ambulatory pre-LT factors to identify patients at increased risk of post-LT mortality. Hepatology. 2026 Feb 01; 83(2):294-303.
    View in: PubMed
    Score: 0.021
  17. Outcomes and Resource Utilization in Liver Transplant Recipients Who Underwent Expedited Transplant Evaluation. Prog Transplant. 2023 09; 33(3):223-228.
    View in: PubMed
    Score: 0.018
  18. Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study. Hepatology. 2022 06; 75(6):1471-1479.
    View in: PubMed
    Score: 0.017
  19. Association of Frailty and Sex With Wait List Mortality in Liver Transplant Candidates in the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study. JAMA Surg. 2021 03 01; 156(3):256-262.
    View in: PubMed
    Score: 0.016
  20. Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates. Hepatology. 2021 03; 73(3):1132-1139.
    View in: PubMed
    Score: 0.015
  21. Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma. Gastroenterology. 2019 11; 157(5):1253-1263.e2.
    View in: PubMed
    Score: 0.014
  22. Predictors of Systolic Heart Failure and Mortality Following Orthotopic Liver Transplantation: a Single-Center Cohort. Transplant Proc. 2019 Jul - Aug; 51(6):1950-1955.
    View in: PubMed
    Score: 0.014
  23. Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver?Transplantation. Gastroenterology. 2019 Apr; 156(5):1381-1391.e3.
    View in: PubMed
    Score: 0.013
  24. Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia. Am J Transplant. 2018 10; 18(10):2451-2456.
    View in: PubMed
    Score: 0.013
  25. Controversies in early liver transplantation for severe alcoholic hepatitis. Ann Hepatol. 2018 Aug 24; 17(5):759-768.
    View in: PubMed
    Score: 0.013
  26. Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List. Gastroenterology. 2017 10; 153(4):988-995.
    View in: PubMed
    Score: 0.012
  27. Applying reinforcement learning techniques to detect hepatocellular carcinoma under limited screening capacity. Health Care Manag Sci. 2015 Sep; 18(3):363-75.
    View in: PubMed
    Score: 0.010
  28. Clinical yield of diagnostic endoscopic retrograde cholangiopancreatography in orthotopic liver transplant recipients with suspected biliary complications. Liver Transpl. 2012 Dec; 18(12):1479-84.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.